This review provides guidance on managing and preventing venous thromboembolic disease, a major cause of maternal mortality, during pregnancy and the puerperium.
Demands heightened VTE vigilance in pregnancy; leaves open optimal prevention strategies for trials.
The incidence of venous thromboembolic disease increases by a factor of four with pregnancy, and in developed countries pulmonary embolus is the leading cause of maternal death. This review provides guidance on the diagnosis and management of thromboembolic disease in pregnant women, including guidelines for the prophylactic use of anticoagulant agents in women at high risk during pregnancy and the puerperium.
No takes yet. Share an insight, caveat, or question.
Marik et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: